Drugs Trials Snapshot: ITOVEBI
Summary
ITOVEBI is a medicine approved for use along with palbociclib and fulvestrant to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 ...
Description
ITOVEBI is a medicine approved for use along with palbociclib and fulvestrant to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 ...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source